TLDR Cisco Systems beat Q2 earnings expectations with $1.04 per share versus $1.02 estimate and revenue of $15.3 billion versus $15.11 billion forecast NetworkingTLDR Cisco Systems beat Q2 earnings expectations with $1.04 per share versus $1.02 estimate and revenue of $15.3 billion versus $15.11 billion forecast Networking

Cisco (CSCO) Stock Falls on Revenue Guidance Despite Q2 Earnings Beat

2026/02/12 18:01
4 min read

TLDR

  • Cisco Systems beat Q2 earnings expectations with $1.04 per share versus $1.02 estimate and revenue of $15.3 billion versus $15.11 billion forecast
  • Networking segment revenue jumped 21% year-over-year to $8.29 billion, driven by strong AI hardware demand
  • Stock fell 5% in after-hours trading despite earnings beat due to disappointing full-year revenue guidance of $61.2-$61.7 billion versus Wall Street’s $63.9 billion estimate
  • Adjusted gross margin of 67.5% missed expectations of 68.14% as rising memory chip prices weigh on profitability
  • Company launched Silicon One G300 AI chip and expects AI orders to exceed $5 billion for fiscal year

Cisco Systems beat Wall Street’s earnings expectations for its fiscal second quarter but still saw shares drop 5% in after-hours trading. The reaction highlights how even solid results can disappoint when guidance falls short of investor hopes.

The networking giant posted adjusted earnings of $1.04 per share for the quarter, beating analyst estimates of $1.02 per share. Revenue came in at $15.3 billion, topping the $15.11 billion forecast. Not bad at all.

But investors weren’t buying it. The problem? Full-year revenue guidance that came in well below expectations.


CSCO Stock Card
Cisco Systems, Inc., CSCO

Networking Strength Meets Margin Pressure

Cisco’s networking segment delivered the standout performance. Revenue hit $8.29 billion for the quarter, crushing Wall Street’s $7.9 billion estimate. That’s a 21% jump from the prior year, fueled by companies rushing to build out AI infrastructure.

Security revenue told a different story. The segment brought in $2.02 billion, slightly below the $2.11 billion estimate and down 4% year-over-year.

The bigger concern emerged in the margins. Adjusted gross margin landed at 67.5%, missing expectations of 68.14%. Memory chip prices are the culprit here.

Global AI spending has created a memory chip shortage. Prices have spiked as a result. Since Cisco’s products rely heavily on these chips, the cost increases are eating into profitability.

Barclays analysts noted they didn’t expect memory prices to cause this much pain. They suggested the mix of optics and AI switches might also be dragging on margins.

CEO Chuck Robbins addressed the issue directly. He told investors the company has already raised prices and is renegotiating customer contracts. Still, the damage to margins is visible in the numbers.

Guidance Gap Spooks Investors

For the current quarter, Cisco expects earnings between $1.02 and $1.04 per share on revenue of $15.4 billion to $15.6 billion. That’s in line with or slightly above analyst estimates of $1.03 per share and $15.19 billion.

The full-year outlook is where things get messy. Cisco projects earnings of $4.13 to $4.17 per share on revenue of $61.2 billion to $61.7 billion.

Wall Street wanted $4.13 per share on revenue of $63.9 billion. That’s a gap of over $2 billion on the revenue line. Investors noticed.

Cisco stock has been on a tear, up 37% over the past 12 months. Shares hit a record high in December, marking the first time since March 2000 that the stock reached such levels. That was just before the dot-com crash wiped out much of its value.

The recent rally stems from Cisco’s position in the AI hardware buildout. While software stocks have struggled on fears that AI could disrupt the sector, hardware companies like Cisco have attracted investor attention.

Raymond James analyst Simon Leopold noted that tech investors are seeking AI hardware as an alternative to challenged software stocks. He rates the stock as Market Perform without a price target.

Cisco announced Tuesday it launched the Silicon One G300 AI chip. William Blair analyst Sebastien Naji wrote that the move shows Cisco wants to capture the entire AI market. The company is building a complete product stack from silicon to optics, hardware, and software.

Robbins said in the earnings release that Cisco is uniquely positioned to deliver the infrastructure needed for the AI era. The company expects AI orders to exceed $5 billion for the current fiscal year, up from previous estimates. That demand continues to drive the networking segment’s strong performance despite margin headwinds.

The post Cisco (CSCO) Stock Falls on Revenue Guidance Despite Q2 Earnings Beat appeared first on CoinCentral.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$0.24998
$0.24998$0.24998
+7.71%
USD
Audiera (BEAT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

U.S. Moves Grip on Crypto Regulation Intensifies

U.S. Moves Grip on Crypto Regulation Intensifies

The post U.S. Moves Grip on Crypto Regulation Intensifies appeared on BitcoinEthereumNews.com. The United States is contending with the intricacies of cryptocurrency regulation as newly enacted legislation stirs debate over centralized versus decentralized finance. The recent passage of the GENIUS Act under Bo Hines’ leadership is perceived to skew favor towards centralized entities, potentially disadvantaging decentralized innovations. Continue Reading:U.S. Moves Grip on Crypto Regulation Intensifies Source: https://en.bitcoinhaber.net/u-s-moves-grip-on-crypto-regulation-intensifies
Share
BitcoinEthereumNews2025/09/18 01:09
WTI jumps above $70.50 on fears of Iran supply disruption

WTI jumps above $70.50 on fears of Iran supply disruption

The post WTI jumps above $70.50 on fears of Iran supply disruption appeared on BitcoinEthereumNews.com. West Texas Intermediate (WTI), the US crude oil benchmark
Share
BitcoinEthereumNews2026/03/02 09:44
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11